Komori
KYORIN Pharmaceutical (4569) · InitiativeAdvanced

Introducing a CxO-Based Executive Management and Delegation-of-Authority Structure

First written in FY2024. 1 of 2 entries say "Advanced", first in FY2026. Latest entry: FY2026.

2entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY20242024: 120242025: 020252026: 12026
Same theme, other companies
Function-Based Group Governance through a CxO SystemA theme 37 companies write about · 0 as a headwind · 38 as a tailwind

The whole theme swung hardest in 2026: 3 of 28 companies on the "Worse" side.

15 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 37 companies compared. The sentences above are computed from all 37.
Introducing a CxO-Based Executive Management and Delegation-of-Authority Structure | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori